The student will be able to understand the current challenges of the health care system in terms of managing therapeutic innovation and to outline and critically interpret cost-effectiveness analyses of medicines.
The objectives of the course are: -understand the context and rationale of pharmacoeconomics (the "why") -acquire the key analytical concepts used in pharmacoeconomics (the "how")
The course presents both the context and the methodological outlines of pharmaco-economics
Written examination. The exact modalities of the assessment are subject to change when the examination timetable is being drawn up, depending on practical constraints that the faculty administration may face, or in case of illness/force majeure/emergency with a placement, or because of the health situation related to the coronavirus.
The course slides as well as the methodological recommendations of the KCE (Belgium) and the HAS (France) are provided to the students.
| Training | Study programme | Block | Credits | Mandatory |
|---|---|---|---|---|
| Master 120 en sciences pharmaceutiques, à finalité spécialisée | Standard | 0 | 2 | |
| Master 120 en sciences pharmaceutiques, à finalité spécialisée | Standard | 1 | 2 |